Remove 2011 Remove Development Remove Pharmaceuticals Remove Productivity
article thumbnail

3 Ways to Confront Economic Adversity in 2011

Coaching Tip

Transforming time from an adversary into an ally has helped me develop the positive mindset to be able to dust myself off from my own early business failures and build my company, Weatherchem, into the leader in my industry. . Bottom line, the American economy is multi-faceted, robust and resilient.

article thumbnail

Performance Measurement

Strategy Driven

They might include sales productivity metrics such as market share, the company’s ability to charge premium prices relative to peers, or sales force productivity. Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth.

ROIC 62
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The State of Strategy Consulting, 2011

Harvard Business Review

The days when you could make a living responding to companies' discovery of strategy, as in "Gosh, we gotta get ourselves one of those," are gone with the 1970s (or maybe the 1990s in the "developing world"). Strategy has triumphed, the installed base is huge, no self-respecting company would be without one. Of course not," he replied.

article thumbnail

Make Your Knowledge Workers More Productive

Harvard Business Review

With scarcely any help from management, knowledge workers can increase their productivity by 20%. Knowledge workers own the means of production — their brains. So large-scale re-engineering programs, productivity drives, and changes to the incentive system are unlikely to work: they can easily be resisted, ignored or gamed.

article thumbnail

Lipitor and iPhone 4s: Setting the Stage for Industry Disruption

Harvard Business Review

The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. The iPhone 4S's story seems to be about a new beginning: the highly anticipated launch of the latest version of a blockbuster consumer-technology product. 30) of a blockbuster prescription drug. Both Pfizer and. Lipitor's Long Good-bye.

article thumbnail

Recommended Resources – An Interview with Paul Leinwand and Cesare Mainardi, authors of The Essential Advantage

Strategy Driven

PL and CM: Coherent companies – those that possess a capabilities system that aligns their strategy with their product/service portfolio – generate superior performance over time, which is what we call the coherence premium. SD : It sounds logical to develop strategy by starting with one’s capabilities. SD : Why now?

article thumbnail

Big Pharma's Mixed Modes of Growth

Harvard Business Review

Their reliance on alliances and licenses has increased in both product development and marketing and they have become aggressive acquirers. So far have they moved, in fact, that they sometimes sound as if they have altogether abandoned their commitment to internal development. Nonetheless we counsel CEOs to mind the rhetoric.